CollPlant Biotechnologies Ltd - Ordinary Shares New
CLGN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.73M
Close$
$-0.11
102.8% downside
Current Fair Value
102.8% downsideOvervalued by 102.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.73 Million |
|---|---|
| Enterprise Value | $5.44 Million |
| Earnings per Share | $-9.4 |
| Beta | 0.76 |
| Outstanding Shares | 1,442,626 |
Return
| Return on Equity | -424.89% |
|---|---|
| Return on Assets | -173.86% |
| Return on Invested Capital | -262.81% |
Valuation & Multiples
| P/E Ratio | -0.42 |
|---|---|
| PEG | 2.28 |
| Price to Sales | - |
| Price to Book Ratio | 1.99 |
| Enterprise Value to Revenue | 17.1 |
| Enterprise Value to EBIT | -0.44 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
$-2.45
Consensus analyst estimateRevenue Estimate
$480,000
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.53
Consensus analyst estimateRevenue Estimate
$520,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $25▼ 34.21% |
| Investors Holding | 10% |
About CollPlant Biotechnologies Ltd
CEO: Yehiel Tal
